# FDA Inspection 1013036 - Sandoz Incorporated - March 29, 2017

Source: https://www.keypedia.com/records/fda_inspections/sandoz-incorporated/c5a4843e-a101-4f8a-a53e-c497aa2bacd2
Source feed: FDA_Inspections

> FDA Inspection 1013036 for Sandoz Incorporated on March 29, 2017. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1013036
- Company Name: Sandoz Incorporated
- Inspection Date: 2017-03-29
- Classification: No Action Indicated (NAI)
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 1087173 - 2019-04-16](https://www.keypedia.com/records/fda_inspections/sandoz-incorporated/1753bbcb-38cd-4266-b013-2cf283d256a3)
- [FDA Inspection 981954 - 2015-10-30](https://www.keypedia.com/records/fda_inspections/sandoz-incorporated/0604c029-b6de-45ff-91d6-20bd69522fd9)
- [FDA Inspection 853190 - 2013-10-17](https://www.keypedia.com/records/fda_inspections/sandoz-incorporated/365d2763-8443-4d1e-947f-7ef720539d48)
- [FDA Inspection 853190 - 2013-10-17](https://www.keypedia.com/records/fda_inspections/sandoz-incorporated/320dae75-b782-42ef-9345-b04788aa39ad)
- [FDA Inspection 797878 - 2012-08-14](https://www.keypedia.com/records/fda_inspections/sandoz-incorporated/7cf90f89-c67f-415b-b6a4-08e20b3c6a23)

Company: https://www.keypedia.com/companies/sandoz-incorporated/6aa8ae0e-b0f0-49a7-a584-c6e6796c6481

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c